# Seer to Report First Quarter 2026 Financial Results on May 13, 2026
Canonical URL: https://biopharmsignal.com/news/SEER/seer-to-report-first-quarter-2026-financial-results-on-may-13-2026
Ticker: SEER
Company: Seer, Inc
Source: Seer, Inc
Published: 2026-04-29 20:05 EST
Original Source URL: https://investor.seer.bio
## Summary

REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the first quarter 2026 on Wednesday, May 13, 2026.

## Article Body
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the first quarter 2026 on Wednesday, May 13, 2026.
## Recent Company News
- 2026-06-03 22:00 EST — [Seer Files Definitive Proxy Materials and Mails Letter to Stockholders](https://biopharmsignal.com/news/SEER/seer-files-definitive-proxy-materials-and-mails-letter-to-stockholders) — Source: Seer, Inc
- 2026-05-29 11:00 EST — [Seer Files ITC Complaint Against Nanomics](https://biopharmsignal.com/news/SEER/seer-files-itc-complaint-against-nanomics) — Source: Seer, Inc
- 2026-05-26 20:05 EST — [Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026](https://biopharmsignal.com/news/SEER/seer-to-showcase-ai-driven-multi-cancer-screening-approach-and-next-generation-proteomics-capabilities-at-asms-2026) — Source: Seer, Inc
- 2026-05-21 20:39 EST — [Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group](https://biopharmsignal.com/news/SEER/seer-board-of-directors-unanimously-rejects-further-revised-unsolicited-proposal-from-radoff-jec-group) — Source: Seer, Inc
- 2026-05-13 20:05 EST — [Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook](https://biopharmsignal.com/news/SEER/seer-reports-first-quarter-2026-financial-results-and-reaffirms-full-year-2026-outlook) — Source: Seer, Inc
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)